english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Drugs to avoid in 2026

Enfortumab vedotin (Padcev°) + pembrolizumab (Keytruda°) in unresectable or metastatic urothelial carcinoma

Sotatercept (Winrevair°) in pulmonary arterial hypertension

Anabolic androgenic steroids: cardiac events and venous thromboembolism

mRNA covid-19 vaccines: a review of adverse effects (continued)

Drugs to avoid in the name of better patient care: 2026 update

Retracted articles continue to do harm

Fezolinetant (Veoza°) for menopause-related hot flushes

Momelotinib (Omjjara°) in myelofibrosis

Cabergoline: fibrotic disorders and heart valve disease

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90